Renaissance Technologies LLC Has $4.97 Million Stock Position in ZimVie Inc. (NASDAQ:ZIMV)

Renaissance Technologies LLC trimmed its position in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 8.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 356,300 shares of the company's stock after selling 32,900 shares during the period. Renaissance Technologies LLC owned approximately 1.29% of ZimVie worth $4,970,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Barclays PLC boosted its position in shares of ZimVie by 338.4% during the 3rd quarter. Barclays PLC now owns 43,437 shares of the company's stock worth $690,000 after acquiring an additional 33,529 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of ZimVie by 66.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company's stock valued at $2,911,000 after purchasing an additional 73,395 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of ZimVie by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 646,564 shares of the company's stock valued at $10,263,000 after purchasing an additional 15,053 shares during the last quarter. Principal Financial Group Inc. acquired a new position in shares of ZimVie during the 3rd quarter worth $275,000. Finally, Bank of New York Mellon Corp lifted its position in shares of ZimVie by 0.9% during the 4th quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company's stock worth $1,404,000 after buying an additional 943 shares during the last quarter. 95.63% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have commented on ZIMV shares. Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th. B. Riley assumed coverage on shares of ZimVie in a research note on Thursday, April 10th. They set a "buy" rating and a $16.00 target price on the stock.

ZimVie Trading Up 2.0 %

Shares of ZIMV stock traded up $0.18 during mid-day trading on Wednesday, reaching $9.38. 116,019 shares of the stock traded hands, compared to its average volume of 222,732. The company has a market cap of $261.20 million, a price-to-earnings ratio of -0.72 and a beta of 2.14. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. The stock's fifty day simple moving average is $11.39 and its two-hundred day simple moving average is $13.18. ZimVie Inc. has a 1-year low of $8.56 and a 1-year high of $22.40.

ZimVie (NASDAQ:ZIMV - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.25 by $0.02. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The business had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. On average, research analysts anticipate that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.